MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pnpbp.2012.06.024

Медицинская библиотека · Progress in neuro-psychopharmacology & biological psychiatry · 2012

Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia.

Na Kyoung-Sae, Kim Won-Hyoung, Jung Han-Yong, Ryu Seong Gon, Min Kyung Joon, Park Ki-Chang, Kim Yong-Sik, Yoon Jin-Sang, Ahn Yong Min, Kim Chul-Eung

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Metabolic syndrome and antipsychotic medications are associated with inflammation. This study investigated the relationship between inflammation and metabolic syndrome in patients with schizophrenia. It also examined the effects of paliperidone extended release (ER) treatment on metabolic parameters.

METHODS

Data were analyzed from schizophrenic patients who participated in a multi-center, open-label, non-comparative clinical trial. Anthropomorphic measurements (i.e., weight, waist circumference, and blood pressure) were assessed along with fasting laboratory values, including white blood cell (WBC) count, glucose, high-density lipoprotein, and triglycerides.

RESULTS

Among the 225 patients at baseline, the group with the highest WBC count displayed a 5.9-fold risk for metabolic syndrome compared with that of the lowest group. An increase of 10(3)WBCs/μL was associated with a 1.4-fold increased risk for metabolic syndrome. After 24weeks of treatment with paliperidone ER, significant increases were observed in waist circumference and body weight. Changes in WBC count were positively correlated with changes in waist circumference.

CONCLUSIONS

Schizophrenic patients with high levels of inflammation should be carefully monitored for metabolic syndrome. Moreover, strategies to reduce inflammation and obesity may prevent metabolic syndrome in patients with schizophrenia who take atypical antipsychotic medication.

Для цитирования: Na Kyoung-Sae, Kim Won-Hyoung, Jung Han-Yong, Ryu Seong Gon, Min Kyung Joon, Park Ki-Chang, Kim Yong-Sik, Yoon Jin-Sang, Ahn Yong Min, Kim Chul-Eung. Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia.. Progress in neuro-psychopharmacology & biological psychiatry. 2012. DOI: 10.1016/j.pnpbp.2012.06.024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.